Á lódáil...
Gene therapy in an era of emerging treatment options for hemophilia B
Factor IX deficiency (hemophilia B) is less common than factor VIII deficiency (hemophilia A) and innovations in therapy for hemophilia B have generally lagged behind those for hemophilia A. Recently the first sustained correction of the hemophilia bleeding phenotype by clotting factor gene therapy...
Na minha lista:
| Foilsithe in: | J Thromb Haemost |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4712690/ https://ncbi.nlm.nih.gov/pubmed/26149016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.12957 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|